The largest database of trusted experimental protocols

6800 system

Manufactured by Roche
Sourced in Germany

The 6800 system is a PCR-based molecular diagnostic instrument designed for clinical laboratories. It is capable of performing automated nucleic acid extraction, amplification, and detection. The 6800 system is intended for use with Roche's validated molecular diagnostic assays.

Automatically generated - may contain errors

9 protocols using 6800 system

1

Automated HPV Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary vials were initially processed by the p 480 v2 (with software 2.1.1) instrument, that performed spin-mixing, cap removal, barcode alignment and transfer of 2-ml sample aliquots to secondary vials, and recapping with the original primary vial cap.
The secondary vials were then manually transferred to the cobas 6800 system, a fully automated unit that provides full sample preparation and HPV detection without further intervention by the operator.
Both cobas HPV real-time PCR assays detect the same 14 types of HPV, use the same primers and probes, and provide partial genotyping for HPV16 and HPV18. The two assays do however differ in their Thermal Cycling (CT) profile (the cobas 6800/8800 runs a universal thermal cycling profile to allow for mixed batching of different PCR tests), as well as in the elution sample volume amplified (50 μl on 6800/8800 vs 150 μl on 4800 out of a 400 μl aliquot of extracted nucleic acids). Both HPV assays were performed according to the manufacturer’s instructions. Each plate, besides the 2 assay’s controls, contained 92 clinical specimens and 2 additional samples (selected from 10 internal and 5 external quality controls, and 2 clinical samples previously found to be invalid by the cobas 4800 HPV test).
+ Open protocol
+ Expand
2

Automated EBV Viral Load Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cobas EBV test was performed on either a cobas 6800 System or a cobas 8800 System (13 ). As these systems are fully automated molecular analyzers, all steps, including primary sample handling, DNA extraction, and PCR amplification, were performed in the same system without further manual intervention. The comparator assay, namely, the CE-IVD-approved (but not FDA-cleared) Abbott RealTime EBV assay, was performed on an m2000 RealTime System (m2000sp instrument for DNA extraction and 2000rt for PCR amplification), according to the manufacturer’s instructions (14 ).
+ Open protocol
+ Expand
3

Comparison of HPV Testing Methods

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pap cytology and human papillomavirus testing Two aliquots were removed from each LBC vial, 1 each for 4800 HPV and 6800/ 8800 HPV testing. The residual LBC sample was used for Pap cytology, followed by CINtec PLUS Cytology for all participants referred for colposcopy and biopsy.
The 4800 HPV test was performed at all 4 participating clinical laboratories; 2 performed the 6800/8800 HPV test using the cobas 6800 System (generates 384 results within an 8-hour shift), and the other 2 performed 6800/8800 HPV using the cobas 8800 System (generates 1056 results within an 8-hour shift). 8 The cycle threshold cutoffs for the 6800/8800 HPV tests were previously established using clinical samples to optimize the assay's sensitivity and specificity for detection of histologically confirmed CIN2. 9, 10, 11 Pap cytology and p16/Ki-67 dual-stained cytology were conducted at the same laboratories. Pap cytology was performed without computerized imaging, central lab cytotechnologists interpreted the Pap slides according to their standard laboratory procedures, and reported these by using the Bethesda nomenclature. 12
+ Open protocol
+ Expand
4

Multiplex RT-PCR for SARS-CoV-2 and Influenza

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the manufacturer’s instructions, Roche Diagnostics K.K. performed the assay using cobas SARS-CoV-2 & Influenza A/B on a cobas 6800 system. Eight hundred microliters of the sample was transferred to a cobas omni secondary tube and loaded onto the assay machine. Sample preparation, reverse transcription of the target RNA to complementary DNA, and real-time multiplexed PCR were automatically performed on the system. The targets were genes of membrane proteins 1 and 2 for influenza A virus, genes of nonstructural and nuclear export proteins for influenza B virus, and open reading frame 1a/b and envelope protein genes for SARS-CoV-2. Positive, negative, and internal controls were used for each assay. The system displayed the validity of the test and detection results for each target. According to the manufacturer’s instructions, the limits of detection were 0.026–0.14, 0.017–0.053, and 0.0079–0.12 50% tissue culture infectious dose (TCID50)/mL for influenza A virus, influenza B virus, and SARS-CoV-2, respectively.
+ Open protocol
+ Expand
5

SARS-CoV-2 Detection using Cobas 6800

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOPS were automatically processed by the cobas® 6800 system, TNA from patient samples were extracted together with the RNA internal control. As described by the manufacture, sequences of the open reading frame (ORF)-1 of the non-structural region served as SARS-CoV-2-specific Roche-Cobas-Target1, while conserved regions in the structural E-gene served as Roche-Cobas-Target2.
+ Open protocol
+ Expand
6

Comparative Analysis of HIV-1 Quantitative Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Hologic Aptima HIV-1 Quant Dx assay was used on the fully automated Panther system (Hologic, Inc., San Diego, CA). The assay targets the polymerase (pol) and long terminal repeat (LTR) regions. The assay has a minimal required sample volume of 0.7 ml of specimen (0.5 ml plus 0.2 ml of dead volume) and reports quantitative HIV-1 results in a range of 30 to 10,000,000 copies/ml (22 ).
The Roche Cobas HIV-1 assay was performed on the fully automated 6800 system (Roche Molecular Diagnostics, Pleasanton, CA). The assay targets the gag gene and LTR region (dual target). The assay requires at least 0.655 ml of specimen (0.5 ml plus 0.15 ml of dead volume) and reports quantifiable HIV-1 results between 20 and 10,000,000 copies/ml (23 ).
The Abbott RealTime HIV-1 Quant Dx assay was used on the automated m2000 system (Abbott Molecular, Inc., Des Plaines, IL). The assay targets the pol integrase region (single target). The assay is designed to use 0.2, 0.5, 0.6 (used in this study), or 1.0 ml of specimen and reports quantifiable HIV-1 results over the range of 40 to 10,000,000 copies/ml (24 ).
+ Open protocol
+ Expand
7

SARS-CoV-2 Detection via RT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were subjected to PCR-RNA for SARS-CoV-2 (COBAS6800, Roche, India Qiagen, Germany) for use on the cobas® 6800 System. Nasopharyngeal and oropharyngeal swab samples were collected on 0.9% physiological saline. Selective amplification of target nucleic acid from the sample was achieved using specific forward and reverse primers for ORF1 a/b non-structural region that is unique to SARS-CoV-2. The pan-Sarbecovirus detection sets also detected the SARS-CoV-2 virus. Amplification of RNA Internal Control was achieved using non-competitive sequence-specific forward and reverse primers, which have no homology with the coronavirus genome. DNA polymerase enzyme was used for amplification.
+ Open protocol
+ Expand
8

COVID-19 Diagnostic Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
COVID-19 testing: For RNA extraction, we used Qiagen EZ1 Virus mini kit extraction (Qiagen, Hilden, Germany). For real-time polymerase chain reaction (RT PCR) amplification, we used Roche cobas® SARS-CoV-2 Qualitative assay on 6800 System (Roche Diagnostics Nederland B.V., Netherland). Serum TSH, FT4, and T3 were all measured by electrochemiluminescence assays on Cobas e 801 immunoassay analyzer (Roche Diagnostics GmbH, Mannheim, Germany).
+ Open protocol
+ Expand
9

SARS-CoV-2 Viral Load Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
All NPS samples were analyzed using the Cobas® SARS-CoV-2 RT-PCR assay on the 6800 system (Roche), targeting ORF1 and the E-gene. To convert Ct values into RNA copy numbers, we tested serial of dilutions of cultured SARS-CoV-2, which were quantified by using in vitro transcribed RNA obtained from the European Virus Archive [15 ] by using the Charité E gene assay [16 ]. Cycle-threshold (Ct) values for the E-gene were converted into viral load (VL) with the following formula: log10 SARS-CoV-2 copies/mL = (Ct-44.5)/-3.3372.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!